Spasticity vs. Trigger Points: Two Problems, One Wrong Name

The term "muscle relaxant" creates a dangerous expectation: if the muscle is tense and painful, a relaxant should resolve it. But this logic only works when the muscle tension is of central origin — as in post-stroke spasticity, multiple sclerosis, or spinal cord injuries. In these conditions, the upper motor neuron is hyperactive and drugs that reduce this hyperactivity have a precise indication.

In myofascial pain from trigger points, the mechanism is completely different. The palpable knot is not the result of an excessive command from the central nervous system to the muscle. It is a sustained local contraction, maintained by a dysfunctional motor end plate that releases acetylcholine in excess — the só-called active locus of the trigger point. The origin is peripheral, not central.

Prescribing cyclobenzaprine for a trapezius trigger point is like trying to put out a kitchen fire by cutting power to the entire house: the fire continues, and now you're in the dark.

Central Spasticity vs. Trigger-Point Contraction

FeatureSpasticity (Central)Trigger Point (Peripheral)
OriginUpper motor neuron (brain/spinal cord)Dysfunctional motor end plate (local)
MechanismHyperexcitability of the stretch reflexExcessive acetylcholine release + energy crisis
DistributionHemibody or limb patternFocal taut band in specific muscle
On examinationVelocity-dependent hypertoniaPalpable nodule with referred pain
Response to muscle relaxantsGood — reduces tone via CNSPoor — the target is peripheral
Response to needling/EALimitedGood to moderate, with heterogeneous evidence — acts directly on the active locus
Comparative diagram: neural pathways of spasticity (upper motor neuron → spinal cord → muscle) vs. trigger-point pathogenesis (motor end plate → local contraction → hypoxia → nociceptor sensitization)
Comparative diagram: neural pathways of spasticity (upper motor neuron → spinal cord → muscle) vs. trigger-point pathogenesis (motor end plate → local contraction → hypoxia → nociceptor sensitization)

How Muscle Relaxants Act

The most commonly prescribed muscle relaxants worldwide — cyclobenzaprine, tizanidine, and carisoprodol — act on the central nervous system. None of them act directly on the muscle or on the motor end plate. Understanding where each one acts is fundamental to predicting when they will work and when they will not.

1

Cyclobenzaprine

Structurally analogous to amitriptyline. Reduces gamma motor neuron activity in the brainstem reticular formation. Decreases muscle tone by reducing descending drive — but trigger points do not depend on this drive.

2

Tizanidine

Central alpha-2 adrenergic agonist. Acts on the locus coeruleus and dorsal horn of the spinal cord, inhibiting release of excitatory neurotransmitters. Effective in spasticity, but trigger points are maintained locally by the motor end plate.

3

Carisoprodol

Metabolized to meprobamate (a carbamate with sedative action similar to that of barbiturates). Diffusely depresses the CNS, causing intense sedation. Dependence potential. Schedule IV in the US (since 2012); banned or restricted in several other countries.

Cyclobenzaprine: Chain of Action

  1. Oral ingestion

    Gastrointestinal absorption, plasma peak in 3-8 hours

  2. Action in the brainstem

    Inhibits reticular formation neurons — reduces gamma motor neuron activity

  3. Reduction of descending drive

    Less tonic facilitation of the spinal stretch reflex

  4. Muscle: reduction in global tone

    Diffuse effect throughout the musculature — not selective for the affected muscle

  5. On the trigger point: no direct effect

    Local contraction is maintained by the motor end plate, not central drive — the drug misses its target

Why Relaxants Fail in Myofascial Pain

Muscle relaxant failure in myofascial pain isn't surprising once we understand the pathophysiology. The myofascial trigger point is sustained by a local vicious cycle that does not depend on excessive central activation.

In Simons' integrated hypothesis, the sequence is: trauma or overload → sarcoplasmic reticulum damage → uncontrolled calcium release → sustained sarcomere contraction → capillary compression → local hypoxia → release of algogenic substances (bradykinin, CGRP, substance P) → nociceptor sensitization → pain. This entire cycle happens in the muscle and at the motor end plate, beyond the reach of drugs that act on the CNS.

Trigger-Point Cycle — Where the Relaxant Does Not Reach

  1. Dysfunctional motor end plate

    Excessive acetylcholine release maintains local contraction

  2. Sustained sarcomere contraction

    Palpable contraction knot — independent of central command

  3. Capillary compression + hypoxia

    Reduced blood flow in the taut band → energy crisis

  4. Release of algogenic substances

    Bradykinin, CGRP, substance P, H⁺ — sensitize local nociceptors

  5. Referred pain + peripheral sensitization

    Aδ and C fiber activation → referred pain in a predictable pattern

  6. Cycle feedback

    Reflex spasm and ischemia perpetuate the contraction — a self-sustaining cycle

Modest
effect size of relaxants over placebo in myofascial pain — short-term trials
Moderate
effect of dry needling/electroacupuncture on trigger points, in heterogeneous studies
Indirect
action of relaxants on the motor end plate — they act on the CNS, not locally
Frequent
drowsiness with cyclobenzaprine — dose-dependent, more common in older adults

Adverse Effects: The Price of Systemic Sedation

Even when muscle relaxants produce some partial relief — often from generalized sedation that reduces pain perception — adverse effects compromise patient functionality. The central mechanism of action ensures that the side effects are systemic and diffuse, affecting cognition, balance, and capacity to work.

Adverse Effects of the Most Prescribed Muscle Relaxants

Adverse EffectCyclobenzaprineTizanidineCarisoprodol
Drowsiness / sedationFrequent (FDA labels: ~32-39% at 10 mg doses; dose-dependent)Frequent, dose-dependent (labels: ~48% in single-dose studies)Very common (main effect)
Dry mouthVery commonCommonOccasional
DizzinessCommonVery commonVery common
HypotensionRareCommon (α2 agonist)Occasional
Cognitive impairmentModerateModerateIntense
Dependence riskLowLowHigh (metabolite: meprobamate)
Interaction with alcoholPotentiates CNS depressionPotentiates hypotensionRisk of respiratory depression
Safety in older adultsBeers criteria — avoidCautionContraindicated

Electroacupuncture: Treating the Correct Target

Electroacupuncture (EA) is the application of pulsed electrical current through acupuncture needles inserted directly into the target tissue. In the context of myofascial pain, the needle is positioned in the trigger point — exactly where the cycle of sustained contraction, hypoxia, and sensitization is occurring. The fundamental difference is that the treatment is local and targeted, not systemic and diffuse.

EA combines two therapeutic mechanisms in a single intervention: the mechanical effect of needling (taut-band disruption, local twitch response) and the electrical effect (neurotransmitter modulation, segmental and supraspinal analgesia).

Mechanisms of Electroacupuncture in the Trigger Point

  1. Needle insertion in the trigger point

    Direct penetration into the taut band — mechanical disruption of the contraction knot

  2. Local twitch response (LTR)

    Brief involuntary contraction → "reset" of the dysfunctional motor end plate

  3. Electrical stimulus at 2 Hz

    Releases enkephalins and β-endorphin — analgesia via μ and δ opioid receptors

  4. Electrical stimulus at 100 Hz

    Releases dynorphins — analgesia via κ opioid receptors in the dorsal horn

  5. Increased local blood flow

    CGRP- and nitric-oxide-mediated vasodilation → reverses taut-band hypoxia

  6. Reduction in algogenic substances

    Decreases bradykinin, substance P, and prostaglandins in the trigger-point interstitial milieu

Clinical photograph: electroacupuncture in upper trapezius trigger point — needles with cables connected to the electrostimulator, alternating frequency 2/100 Hz
Clinical photograph: electroacupuncture in upper trapezius trigger point — needles with cables connected to the electrostimulator, alternating frequency 2/100 Hz

Do

  • Treat the trigger point directly — with needling, electroacupuncture, or injection — when the relaxant fails in myofascial pain
  • Consider an evaluation with a physician acupuncturist if you have been using muscle relaxants for weeks without satisfactory pain improvement
  • Withdrawal of the relaxant, when indicated, should be done gradually and under medical supervision

Avoid

  • Escalate to opioids because the muscle relaxant did not work in myofascial pain
  • Use carisoprodol in older adults, in patients with a history of substance abuse, or for prolonged periods
  • Drive or operate machinery under the effect of the muscle relaxant
The essentials so far
  1. Electroacupuncture (EA) is the application of pulsed electrical current through acupuncture needles inserted directly into the target tissue.
  2. The fundamental difference is that the treatment is local and targeted, not systemic and diffuse.
  3. EA combines two therapeutic mechanisms in a single intervention: the mechanical effect of needling and the electrical effect.
Continue: direct comparison

Direct Comparison: Relaxants vs. Electroacupuncture

The table below summarizes the fundamental differences between pharmacological treatment with muscle relaxants and electroacupuncture for myofascial pain. The contrast between a systemic approach (which misses the target) and a local one (which hits it) explains the difference in clinical results.

Muscle Relaxants vs. Electroacupuncture in Myofascial Pain

ParameterMuscle RelaxantsElectroacupuncture
Therapeutic targetCNS (brainstem, spinal cord)Trigger point in the muscle (peripheral)
SelectivityDiffuse — entire musculaturePrecise — specific muscle and point
Mechanism in myofascial painReduces global tone (wrong target)Deactivates the active locus of the trigger point
SedationYes — main or adverse effectNo — patient alert during and after
Onset of actionHours (peak: 3-8 h)Immediate (local twitch response)
Duration of effectWhile the drug lasts (4-6 h)Days to weeks per session
Adverse effectsDrowsiness, dry mouth, dizziness, fall riskTransient local pain, minimal hematoma
Functional capacityCompromised (no driving, no operating machinery)Preserved — immediate return to activities
Dependence riskYes (especially carisoprodol)No
Evidence in myofascial painModest short-term effect; limited in chronic casesModerate evidence; heterogeneous across studies
Infographic: muscle relaxant (pill icon → brain → diffuse effect throughout the body, with X over the trigger point) vs. electroacupuncture (needle → directly into the trigger point → precise local effect)
Infographic: muscle relaxant (pill icon → brain → diffuse effect throughout the body, with X over the trigger point) vs. electroacupuncture (needle → directly into the trigger point → precise local effect)

Clinical Scenarios: When the Relaxant Fails and the Needle Resolves

The scenarios below are illustrative cases (they do not represent expected results) of patients with myofascial pain who did not respond well to muscle relaxants and were treated with electroacupuncture. Each case highlights why the mechanism of action matters more than the name of the drug class.

Myth vs. Fact

Myth

Muscle relaxants are first-line treatment for muscle pain.

Fact

Muscle relaxants are indicated for acute muscle spasm (cyclobenzaprine, carisoprodol) or central spasticity (tizanidine), and the evidence for myofascial pain from trigger points is limited. In myofascial pain, the mechanism is peripheral (dysfunctional motor end plate), and direct needling — dry or with electroacupuncture — is an option with low to moderate evidence, combined with therapeutic exercise and postural correction.

Myth vs. Fact

Myth

If the muscle relaxant didn't work, the patient needs a stronger analgesic.

Fact

Muscle relaxant failure in myofascial pain doesn't indicate a need to escalate to opioids. It indicates that the mechanism of action was wrong from the start. The next logical step is to treat the trigger point directly — with needling, electroacupuncture, or injection — not to increase the potency of a drug that acts on the wrong target.

Clinical flowchart: patient with muscle pain → assessment: central spasticity? (yes → muscle relaxant indicated) / trigger points? (yes → electroacupuncture + therapeutic exercise) / both? (combined approach under medical supervision)
Clinical flowchart: patient with muscle pain → assessment: central spasticity? (yes → muscle relaxant indicated) / trigger points? (yes → electroacupuncture + therapeutic exercise) / both? (combined approach under medical supervision)

Frequently Asked Questions